About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« More on Getting a Science PhD | Main | Accelerated Approval And Its Discontents »

September 5, 2012

Merck (Germany) Cuts Back

Email This Entry

Posted by Derek

If you haven't heard, Merck KGgA has announced that they're cutting over a thousand jobs in Germany. They'd already cut back hard in the Merck Serono end of the company, and now comes the rest. . .

Comments (4) + TrackBacks (0) | Category: Business and Markets


1. Anonymous on September 5, 2012 9:41 AM writes...

Very fitting that this blog entry is back to back with the one about Daniel Lametti saying that the job situation for Ph.D scientists really isn't that bad.

Permalink to Comment

2. GG on September 6, 2012 7:41 AM writes...

Derek, has productivity in the pharma industry gone down despite all the layoffs? Do you think modern techniques have streamlined productivity making some positions redundant? Or are these things a drop in the bucket compared to outsourcing/lack of willingness to invest in R&D.

Permalink to Comment

3. GG on September 6, 2012 7:43 AM writes...

Oops. I mean as a result of all the layoffs.

Permalink to Comment

4. Ben on September 10, 2012 12:35 PM writes...

I don't believe the cut-backs are as severe as advertised.

A new Merck research facility in China or India will hire 1000 researchers at 1/3 the price. Wage arbitrage at its best.

We may be very well living through a period of great expansion in the pharma industry. Does anyone believe anything one reads in Corporate reports today? Merck may be hiring (or sub-contracting) thousands of workers in India.

Fraud is not just ignored by the SEC (or its foreign equivalents), it is actively covered up with agency help.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Worst Seminar
Conference in Basel
Messed-Up Clinical Studies: A First-Hand Report
Pharma and Ebola
Lilly Steps In for AstraZeneca's Secretase Inhibitor
Update on Alnylam (And the Direction of Things to Come)
There Must Have Been Multiple Chances to Catch This
Weirdly, Tramadol Is Not a Natural Product After All